Alnylam Pharmaceuticals (ALNY) News Today $328.81 +0.81 (+0.25%) Closing price 04:00 PM EasternExtended Trading$328.84 +0.03 (+0.01%) As of 06:35 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ALNY Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Shares Bought by ANTIPODES PARTNERS LtdJuly 25 at 11:18 AM | marketbeat.comBurney Co. Has $1.68 Million Stock Holdings in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)July 25 at 5:22 AM | marketbeat.comY Intercept Hong Kong Ltd Has $1 Million Holdings in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)July 25 at 4:33 AM | marketbeat.comVictory Capital Management Inc. Reduces Stock Position in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)July 25 at 3:53 AM | marketbeat.comRep. Jefferson Shreve Sells Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) StockJuly 24 at 8:05 PM | marketbeat.comProficio Capital Partners LLC Has $218,000 Stock Holdings in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)July 24 at 5:20 AM | marketbeat.comAlnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Receives Average Recommendation of "Moderate Buy" from BrokeragesJuly 24 at 4:53 AM | marketbeat.comAlnylam Pharmaceuticals (ALNY) to Release Earnings on ThursdayJuly 24 at 4:52 AM | marketbeat.comBeacon Investment Advisory Services Inc. Cuts Stock Holdings in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)July 23 at 6:14 AM | marketbeat.comAllianz Asset Management GmbH Purchases 109,632 Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)July 23 at 5:05 AM | marketbeat.comAlnylam Pharmaceuticals (NASDAQ:ALNY) Now Covered by Analysts at Truist FinancialJuly 23 at 4:19 AM | americanbankingnews.comTruist Securities Initiates Coverage of Alnylam Pharmaceuticals (ALNY) with Buy RecommendationJuly 23 at 2:53 AM | msn.comAlnylam’s Zilebesiran Study: A New Hope for Hypertension Management?July 21, 2025 | tipranks.comThis Alnylam Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For MondayJuly 21, 2025 | benzinga.comAlnylam Pharmaceuticals (NASDAQ:ALNY) Now Covered by Truist FinancialJuly 21, 2025 | marketbeat.comLos Angeles Capital Management LLC Trims Stock Holdings in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)July 21, 2025 | marketbeat.comAlnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Shares Sold by Souders Financial AdvisorsJuly 21, 2025 | marketbeat.comTeachers Retirement System of The State of Kentucky Decreases Holdings in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)July 21, 2025 | marketbeat.comJennison Associates LLC Acquires 49,306 Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)July 19, 2025 | marketbeat.comWealthfront Advisers LLC Sells 3,899 Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)July 19, 2025 | marketbeat.comJPMorgan Chase & Co. Forecasts Strong Price Appreciation for Alnylam Pharmaceuticals (NASDAQ:ALNY) StockJuly 19, 2025 | americanbankingnews.comLeerink Partnrs Brokers Reduce Earnings Estimates for ALNYJuly 19, 2025 | americanbankingnews.comAlnylam’s Promising Huntington’s Disease Study: A Potential Game-ChangerJuly 18, 2025 | tipranks.comAlnylam’s ConTTRibute Study: A Closer Look at ATTR Amyloidosis TreatmentJuly 18, 2025 | tipranks.comAlnylam Pharmaceuticals Advances Pregnancy Safety Study for Patisiran-LNPJuly 18, 2025 | tipranks.comAlnylam’s ELEVATE Study: A Closer Look at AHP Treatment and Market ImpactJuly 18, 2025 | tipranks.comHussman Strategic Advisors Inc. Purchases New Shares in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)July 18, 2025 | marketbeat.comCerity Partners LLC Acquires 1,117 Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)July 18, 2025 | marketbeat.comAlnylam to Webcast Conference Call Discussing Second Quarter 2025 Financial ResultsJuly 17, 2025 | businesswire.comKornitzer Capital Management Inc. KS Acquires Shares of 2,000 Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)July 17, 2025 | marketbeat.comLeerink Partnrs Has Pessimistic View of ALNY Q2 EarningsJuly 17, 2025 | marketbeat.comAlnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Shares Purchased by Cwm LLCJuly 17, 2025 | marketbeat.comNew York State Common Retirement Fund Sells 7,956 Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)July 17, 2025 | marketbeat.comEnvestnet Asset Management Inc. Purchases 6,033 Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)July 17, 2025 | marketbeat.comJefferies Remains a Buy on Alnylam Pharma (ALNY)July 16, 2025 | theglobeandmail.comAlnylam Pharma (ALNY) Receives a Buy from CitiJuly 16, 2025 | theglobeandmail.comA Glimpse Into The Expert Outlook On Alnylam Pharmaceuticals Through 10 AnalystsJuly 16, 2025 | benzinga.comAlnylam’s ELEVATE Study: A Closer Look at AHP Treatment AdvancementsJuly 16, 2025 | tipranks.comAlnylam’s ConTTRibute Study: A Closer Look at ATTR Amyloidosis TreatmentJuly 16, 2025 | tipranks.comAlnylam’s ALN-HTT02 Study: A Promising Step in Huntington’s Disease TreatmentJuly 16, 2025 | tipranks.comAlnylam’s Phase 1 Study on ALN-BCAT: A Potential Game-Changer in Liver Cancer TreatmentJuly 16, 2025 | tipranks.comAlnylam’s Phase 1 Study on ALN-4324: A Potential Game-Changer in Obesity Treatment?July 16, 2025 | tipranks.comAlnylam Pharmaceuticals (NASDAQ:ALNY) Given New $348.00 Price Target at JPMorgan Chase & Co.July 16, 2025 | marketbeat.comPrincipal Financial Group Inc. Increases Stake in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)July 15, 2025 | marketbeat.comNisa Investment Advisors LLC Cuts Stock Position in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)July 14, 2025 | marketbeat.comCrossmark Global Holdings Inc. Purchases Shares of 1,018 Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)July 14, 2025 | marketbeat.comBrown Advisory Inc. Reduces Stock Position in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)July 12, 2025 | marketbeat.comPenserra Capital Management LLC Increases Holdings in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)July 12, 2025 | marketbeat.comCitigroup Forecasts Strong Price Appreciation for Alnylam Pharmaceuticals (NASDAQ:ALNY) StockJuly 11, 2025 | marketbeat.comBank of America Issues Positive Forecast for Alnylam Pharmaceuticals (NASDAQ:ALNY) Stock PriceJuly 11, 2025 | marketbeat.com Get Alnylam Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ALNY and its competitors with MarketBeat's FREE daily newsletter. Email Address ALNY Media Mentions By Week ALNY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ALNY News Sentiment▼0.921.06▲Average Medical News Sentiment ALNY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ALNY Articles This Week▼2516▲ALNY Articles Average Week Get Alnylam Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ALNY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Amgen News Gilead Sciences News Vertex Pharmaceuticals News Regeneron Pharmaceuticals News Biogen News United Therapeutics News Neurocrine Biosciences News Incyte News Exelixis News BioMarin Pharmaceutical News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ALNY) was last updated on 7/25/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alnylam Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alnylam Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ALNY Stock Alerts